Inhibitors of metalloproteases, pharmaceutical compositions comp

Organic compounds -- part of the class 532-570 series – Organic compounds – Amino nitrogen containing

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546309, 544159, 514706, C07C32100

Patent

active

059292784

ABSTRACT:
Disclosed are novel inhibitors of metalloproteases, in particular matrix metalloproteases. The disclosed inhibitors are mercaptoketone and mercaptoalcohol compounds which are useful in pharmaceutical compositions and methods for treating or controlling disease states or conditions which involve tissue breakdown, for example, arthropathy, dermatological conditions, bone resorption, inflammatory diseases, and tumor invasion and in the promotion of wound healing.

REFERENCES:
patent: 4235885 (1980-11-01), Sundeen et al.
patent: 4327111 (1982-04-01), Sundeen et al.
patent: 4371466 (1983-02-01), McGregor
patent: 4424354 (1984-01-01), Sundeen et al.
patent: 4511504 (1985-04-01), McCullagh et al.
patent: 4568666 (1986-02-01), McCullagh et al.
patent: 4595700 (1986-06-01), Donald et al.
patent: 4599361 (1986-07-01), Dickens et al.
patent: 4681966 (1987-07-01), Donald et al.
patent: 4720486 (1988-01-01), Spilburg et al.
patent: 4743587 (1988-05-01), Dickens et al.
patent: 4771038 (1988-09-01), Wolanin et al.
patent: 4826815 (1989-05-01), Luly et al.
patent: 4826958 (1989-05-01), Sham
patent: 4857507 (1989-08-01), Rosenburg et al.
patent: 4891356 (1990-01-01), Szabo
patent: 4918105 (1990-04-01), Cartwright et al.
patent: 4935404 (1990-06-01), Hunter et al.
patent: 4937243 (1990-06-01), Markwell et al.
patent: 4996358 (1991-02-01), Handa et al.
patent: 5006651 (1991-04-01), Broadhurst et al.
patent: 5010097 (1991-04-01), Markwell et al.
patent: 5100874 (1992-03-01), Odake et al.
patent: 5109000 (1992-04-01), Markwell et al.
patent: 5217878 (1993-06-01), van Eekelen et al.
patent: 5240958 (1993-08-01), Campion et al.
patent: 5256657 (1993-10-01), Singh et al.
patent: 5304604 (1994-04-01), Davidson et al.
patent: 5310763 (1994-05-01), Campion et al.
patent: 5387610 (1995-02-01), Gray et al.
patent: 5594106 (1997-01-01), Black et al
patent: 5629285 (1997-05-01), Black et al.
Schwartz et al., Progress in Med. Chem., vol. 29, pp. 271-333, 1992.
Beszant et al. (1993), "Synthesis of novel modified dipeptide inhibitors of human collagenase: .beta.- mercapto carboxylic acid derivatives," J. Med. Chem. 36 (25): 4030-4039.
Bird et al. (1994), "Synthesis of novel n-phosphonoalkyl dipeptide inhibitors of human collagenase," J. Med. Chem. 37: 158-169.
Bode et al. (1992), "Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases," Nature 358: 164-167.
Brown et al. (1994), "Matrix metalloproteinase inhibitors containing a (carboxyalkyl)amino zinc ligand: modification of the P1 and P2' residues," J. Med. Chem. 37: 674-688.
Chapman et al. (1993) "Inhibition of matrix metalloproteinases by n-carboxyalkyl peptides," J. Med. Chem. 36: 4293-4301.
Clark et al. (1985), "A novel inhibitor of mammalian collagenase," Life Sciences 37: 575-578.
Darlak et al. (1990), "Thiol-based inhibitors of mammalian collagenase," J. Biol. Chem. 265 (9): 5199-5205.
Docherty et al. (1992), "The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases," TibTech 10: 200-206.
Galardy et al. (1992), "Inhibition of human skin fibroblast collagenase by phosphorus containing peptides," Matrix 1: 259-262.
Gearing et al. (1994), "Processing of tumor necrosis factor-.alpha. precursor by metalloproteinases," Nature 370: 555-557.
Goulet et al. (1994), "Inhibition of stromelysin-1 (MMP-3) by peptidyl phosphinic acids," Bioorganic & Medicinal Chem. Letters 4 (10): 1221-1224.
Gray et al. (1992), "Design and synthesis of inhibitors of porcine synovial collagenase and gelatinase," Matrix (1): 307-308.
Kortylewicz et al. (1989), "Phthaloyl-Glycyl.sup..rho. -isoleucyl-tryptophan benzylamide is a potent inhibitor of human skin fibroblast collagenase with K.sub.i of 25 nM," J. Enzyme Inhibition 3: 159-162.
Gray et al. (1981), "Metal binding peptide inhibitors of vertebrate collagenase," Biochem. Biophys. Res. Comm. 101 (4): 1251-1258.
Gray et al. (1986), "Inhibition of mammalian collagenases by thiol-containing peptides," J. Cell. Biochem. 32:71-77.
Grobelny et al. (1992), "Inhibition of human skin fibroblast collagenase, thermolysin and pseudomonas aeruginosa elastase by peptide hydroxamic acids," Biochem. 31: 7152-7154.
Knight et al. (1992), "A Novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases," FEBS 296 (3): 263-266.
Kortylewicz et al. (1990), "Phosphoramidate peptide inhibitors of human skin fibroblast collagenase," J. Med. Chem. 33 (1): 263-273.
Lin et al. (1992), "Inhibition of human fibroblast collagenase by phthaloyl-glycyl.sup..rho. -isoleucyl-tryptophan benzylamide," Matrix Supplement (1): 311-312.
Lovejoy et al. (1994), "Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor," Science 263: 375-377.
Martin et al. (1993), "Cyclopropanes as conformationally restricted peptide isosteres design and synthesis of novel collagenase inhibitors," Tetrahedron 49 (17): 3521-3532.
McGeehan et al. (1994), "Regulation of tumour necrosis factor-.alpha. processing by a metalloproteinase inhibitor," Nature 370: 558-561.
Mookhtiar et al. (1987), "Phosphonamidate inhibitors of human neutrophil collagenase," Biochemistry 26: 1962-1965.
Moore et al. (1986), "Peptide hydroxamic acids inhibit skin collagenase," Biochem. Biophys. Res. Commun. 136 (1): 390-395.
Odake et al. (1990), "Vertebrate collagenase inhibitor. I. tripeptidyl hydroxamic acids," Chem. Pharm. Bull. 38 (4): 1007-1011.
Pegoraro et al., "Conformationally constrained peptide inhibitors of collagenase and gelatinase," MEDI, No. 126 (no date given).
Peltonen et al. (1985), "Enzymes converting procollagens to collagens," J. Cell. Biochem. 28: 15-21.
Schwartz et al. (1991) "Inhibition of human collagenases by sulfur-based substrate analogs," Biochem. Biophys. Res. Commun. 176(1): 173-179.
Schwartz et al. (1992), "Synthetic inhibitors of bacterial and mammalian interstital collagenases," Progress in Medicinal Chemistry 29: 271-333.
Vencill et al. (1985), "Clostridium histolyticum collagenase: development of new thio ester, flurogenic, and depsipeptide substrates and new inhibitors," Biochem. 24: 3149-3157.
Weingarten et al. (1985), "Synthetic substrates of vertebrate collagenase," Biochem. 24: 6730-6734.
Yankeelov et al. (1978), "Mercaptoimidazolylpropionic acid hydrobromide. inhibition of tadpole collagenase and related properties," J. Med. Chem. 21 (7): 701-704.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of metalloproteases, pharmaceutical compositions comp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of metalloproteases, pharmaceutical compositions comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of metalloproteases, pharmaceutical compositions comp will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-880289

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.